Artemether
Overview
Artemether is a derivative of artemisinin (herb found in china). Artemether is used for the treatment of malaria (intermittent or remittent diseases characterized by attacks of chills, fever, and sweating and caused by a parasitic protozoan transferred to the human bloodstream by an anopheles mosquito) in combination with other anti-malarial drugs resistant to conventional drugs.
Primary Characterstics
Indications
Back to top
Pharmacokinetics
Back to top
Contraindications
Back to top
Back to top
Side Effects
Back to top
Dosage
Artemether's dosage details are as follows:
| Dose
|
Single Dose
|
Frequency
|
Route
|
Instructions
|
Adult Dosage
|
| 160 mg | 160 (160) | 24 hourly | PO,IM | Initial |
| 80 mg | 80 (80) | 24 hourly | PO.IM | Maintenance, As Required |
Paedriatic Dosage (20kg)
|
| 3.2 mg/kg | 3.2 (3.2) | 12 hourly | Intra Muscular | For 3 Days |
Neonatal Dosage (3kg)
|
| No data regarding the neonatal dosage details of Artemether is available. |
High Risk Groups
Back to top
Warning / Precautions
Back to top
Storage Conditions
Back to top
Interference in Pathology
Back to top
Brands / Trade Names of
Artemether
Back to top
Previous Drug Generic - Next Drug Generic